Conference Call: Alkermes Sees Q3 Sales $450.000M-$470.000M vs $472.751M Est

Benzinga Newsdesk www.benzinga.com Positive 76.5%

Neg 0% Neu 0% Pos 76.5%

Alkermes (NASDAQ:ALKS) sees Q3 sales of $450.000 million-$470.000 million vs $472.751 million analyst estimate.

Comments

No comments yet. Be the first!